SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Delia Colombo, Giovanni Abbruzzese, Angelo Antonini, Paolo Barone, Gilberto Bellia, Flavia Franconi, Lucia Simoni, Mahmood Attar, Emanuela Zagni, Shalom Haggiag, Fabrizio Stocchi, The “Gender Factor” in Wearing-Off among Patients with Parkinson’s Disease: A Post Hoc Analysis of DEEP Study, The Scientific World Journal, 2015, 2015, 1

    CrossRef

  2. 2
    F. Stocchi, A. Antonini, P. Barone, M. Tinazzi, M. Zappia, M. Onofrj, S. Ruggieri, L. Morgante, U. Bonuccelli, L. Lopiano, P. Pramstaller, A. Albanese, M. Attar, V. Posocco, D. Colombo, G. Abbruzzese, Early DEtection of wEaring off in Parkinson disease: The DEEP study, Parkinsonism & Related Disorders, 2014, 20, 2, 204

    CrossRef

  3. 3
    Yasuaki Mizutani, Tomohiko Nakamura, Akinori Okada, Junichiro Suzuki, Hirohisa Watanabe, Masaaki Hirayama, Gen Sobue, Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 5, 520

    CrossRef

  4. 4
    Gilad Yahalom, Yael Orlev, Oren S. Cohen, Evgenia Kozlova, Eitan Friedman, Rivka Inzelberg, Sharon Hassin-Baer, Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation, Movement Disorders, 2014, 29, 8
  5. 5
    Hideyuki Matsumoto, Renpei Sengoku, Yuko Saito, Yukio Kakuta, Shigeo Murayama, Ichiro Imafuku, Sudden death in Parkinson's disease: A retrospective autopsy study, Journal of the Neurological Sciences, 2014, 343, 1-2, 149

    CrossRef

  6. 6
    M.R.A. van Hooren, L.W.J. Baijens, S. Voskuilen, M. Oosterloo, B. Kremer, Treatment effects for dysphagia in Parkinson's disease: A systematic review, Parkinsonism & Related Disorders, 2014, 20, 8, 800

    CrossRef

  7. 7
    Scott J. Johnson, Melissa D. Diener, Anna Kaltenboeck, Howard G. Birnbaum, Andrew D. Siderowf, An economic model of Parkinson's disease: Implications for slowing progression in the United States, Movement Disorders, 2013, 28, 3
  8. 8
    Asako Yoritaka, Yasushi Shimo, Masashi Takanashi, Jiro Fukae, Taku Hatano, Toshiki Nakahara, Nobukazu Miyamato, Takao Urabe, Hideo Mori, Nobutaka Hattori, Motor and non-motor symptoms of 1453 patients with Parkinson's disease: Prevalence and risks, Parkinsonism & Related Disorders, 2013, 19, 8, 725

    CrossRef

  9. 9
    R.L. Albin, Encyclopedia of Sleep, 2013,

    CrossRef

  10. 10
    Connie Marras, How will epidemiology shape our knowledge of the patterns of disease progression in Parkinson’s disease?, Basal Ganglia, 2012, 2, 4, 171

    CrossRef

  11. 11
    David A. Gallagher, Christopher G. Goetz, Glenn Stebbins, Andrew J. Lees, Anette Schrag, Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease, Movement Disorders, 2012, 27, 1
  12. 12
    Oscar S. Gershanik, Clinical problems in late-stage Parkinson’s disease, Journal of Neurology, 2010, 257, S2, 288

    CrossRef

  13. 13
    Kumar M Prakash, Eng-King Tan, Development of Parkinson’s disease biomarkers, Expert Review of Neurotherapeutics, 2010, 10, 12, 1811

    CrossRef

  14. 14
    Jose A Obeso, Maria C Rodriguez-Oroz, Christopher G Goetz, Concepcion Marin, Jeffrey H Kordower, Manuel Rodriguez, Etienne C Hirsch, Matthew Farrer, Anthony H V Schapira, Glenda Halliday, Missing pieces in the Parkinson's disease puzzle, Nature Medicine, 2010, 16, 6, 653

    CrossRef

  15. 15
    Ying Jiao Zhao, Hwee Lin Wee, Yiong-Huak Chan, Soo Hoon Seah, Wing Lok Au, Puay Ngoh Lau, Emmanuel Camara Pica, Shu Chuen Li, Nan Luo, Louis C.S. Tan, Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times, Movement Disorders, 2010, 25, 6
  16. 16
    Hideki Mochizuki, Treatment and pathogenesis of Parkinson's disease, Rinsho Shinkeigaku, 2010, 50, 9, 623

    CrossRef

  17. 17
    Genko Oyama, Akito Hayashi, Yoshikuni Mizuno, Nobutaka Hattori, Mechanism and treatment of dropped head syndrome associated with parkinsonism, Parkinsonism & Related Disorders, 2009, 15, 3, 181

    CrossRef

  18. 18
    Walter Maetzler, Inga Liepelt, Daniela Berg, Progression of Parkinson's disease in the clinical phase: potential markers, The Lancet Neurology, 2009, 8, 12, 1158

    CrossRef

  19. 19
    Hideki Mochizuki, The studies of gene therapy for Parkinson's disease, Rinsho Shinkeigaku, 2009, 49, 1, 9

    CrossRef

  20. 20
    Akira Taniguchi, Yugo Narita, Yutaka Naito, Shigeki Kuzuhara, An analysis of application form of Parkinson's disease provided by the specific diseases treatment research program of Ministry of Health, Labour and Welfare of Japan, Rinsho Shinkeigaku, 2008, 48, 2, 106

    CrossRef

  21. 21
    Leslie W. Ferguson, Michele L. Rajput, Nazeem Muhajarine, Syed M. Shah, Alexander Rajput, Clinical features at first visit and rapid disease progression in Parkinson's disease, Parkinsonism & Related Disorders, 2008, 14, 5, 431

    CrossRef

  22. You have free access to this content22
    Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B. Stern, Richard Dodel, Bruno Dubois, Robert Holloway, Joseph Jankovic, Jaime Kulisevsky, Anthony E. Lang, Andrew Lees, Sue Leurgans, Peter A. LeWitt, David Nyenhuis, C. Warren Olanow, Olivier Rascol, Anette Schrag, Jeanne A. Teresi, Jacobus J. van Hilten, Nancy LaPelle, Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results, Movement Disorders, 2008, 23, 15
  23. 23
    Jung-Hwa Seo, Sang-Myung Cheon, Jae Woo Kim, The Correlation of ON and OFF Status With Clinical Characteristics in Patients With Parkinson’s Disease, Journal of Movement Disorders, 2008, 1, 2, 65

    CrossRef

  24. 24
    Nobutaka Hattori, Shigeto Sato, Animal models of Parkinson's disease: Similarities and differences between the disease and models, Neuropathology, 2007, 27, 5
  25. 25
    John C. Morgan, Kapil D. Sethi, Efficacy and safety of pramipexole in restless legs syndrome, Current Neurology and Neuroscience Reports, 2007, 7, 4, 273

    CrossRef